Zobrazeno 1 - 5
of 5
pro vyhledávání: '"James M. Jurica"'
Autor:
Tejas Patil, MD, Alyse Staley, MS, Yunan Nie, MD, Mandy Sakamoto, MD, Margaret Stalker, MD, James M. Jurica, MD, MBA, Kenna Koehler, BA, Amanda Cass, PharmD, Halle Kuykendall, BA, Emily Schmitt, MS, Emma Filar, BA, Evelina Reventaite, MS, Kurt D. Davies, PhD, Hala Nijmeh, PhD, Mary Haag, PhD, Benjamin A. Yoder, PharmD, Paul A. Bunn, MD, Erin L. Schenk, MD, PhD, Dara L. Aisner, MD, PhD, Wade T. Iams, MD, Melina E. Marmarelis, MD, D. Ross Camidge, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100637- (2024)
Introduction: Acquired MET gene amplification, MET exon 14 skip mutations, or MET fusions can emerge as resistance mechanisms to tyrosine kinase inhibitors (TKIs) in patients with lung cancer. The efficacy and safety of combining MET TKIs (such as cr
Externí odkaz:
https://doaj.org/article/63d7bcf67c604305b7273bb565a9b37b
Publikováno v:
Rep Pract Oncol Radiother
Jehovah’s Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::345803ecd8ed54d05400b08aaf7360a0
https://doi.org/10.1016/j.rpor.2020.08.014
https://doi.org/10.1016/j.rpor.2020.08.014
Publikováno v:
HeadneckREFERENCES. 43(3)
Background Delays in treatment of head and neck squamous cell carcinoma (HNSCC) are known to increase disease recurrence, generating the need for additional salvage treatment, often with immunotherapy. Methods Three treatment metrics were identified:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de79ba390545890407d91eafe8bc3c67
https://pubmed.ncbi.nlm.nih.gov/33166016
https://pubmed.ncbi.nlm.nih.gov/33166016
Autor:
Ivo W. Tremont-Lukats, Andrew M. Farach, Eric H. Bernicker, Brian Butler, Shraddha M. Dalwadi, Robert C. Rostomily, Bin Teh, David S. Baskin, James M. Jurica
Publikováno v:
Neuro-oncology Advances
PURPOSE Treatment with stereotactic radiosurgery (SRS) and immune checkpoint inhibitors (ICI) is increasingly common for brain metastases (BM) from lung adenocarcinoma. Rates of radiation necrosis (RN) with SRS in the setting of ICIs is an ongoing ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eab2651c6715464ac23ecd39d0db5887
https://doi.org/10.1093/noajnl/vdaa073.019
https://doi.org/10.1093/noajnl/vdaa073.019
Autor:
Samee A. Hameed, Mia N. Nguyen, Kyana Garza, Richa Chandra, Birgit Mellis, Chandra K. Mittal, Ana V. Hernandez, James M. Jurica
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 462
Background Remnant lipoproteins (RLP) are a metabolically derived subpopulation of triglyceride-rich lipoproteins (TRL) in human blood that are involved in the metabolism of dietary fats or triglycerides. RLP, the smaller and denser variants of TRL p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d885e93c145f7cd2d99d304c7eb59c5b
https://pubmed.ncbi.nlm.nih.gov/27553856
https://pubmed.ncbi.nlm.nih.gov/27553856